Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Prog Urol ; 13(4): 667-9, 2003 Sep.
Artigo em Francês | MEDLINE | ID: mdl-14650301

RESUMO

The authors report a case of left inferior caliceal cystine stones, which recurred despite well conducted medical treatment, 12 extracorporeal lithotripsy sessions, and percutaneous nephrolithotomy. A left lower pole nephrectomy was finally performed. No recurrence on the left side was observed with a follow-up of 3 years. However, the patient developed two recurrences of the right side.


Assuntos
Cálculos Renais/cirurgia , Cálices Renais , Nefrectomia/métodos , Idoso , Cistina/análise , Feminino , Humanos , Cálculos Renais/química , Recidiva
2.
Arch Ophthalmol ; 129(6): 703-8, 2011 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-21320953

RESUMO

OBJECTIVE: To describe foveal damage in habitual use of poppers, a popular recreational drug. METHODS: Retrospective observational case series. Six patients with bilateral vision loss after chronic popper inhalation were seen in 4 university-based ophthalmology departments. Symptoms, medical history, ophthalmic examination, and functional and morphological tests are described. RESULTS: All patients experienced progressive bilateral vision loss, with central photopsia in 2 cases. Initial visual acuities ranged from 20/50 to 20/25. In all patients, a bilateral yellow foveal spot was present that, by optical coherence tomography, was associated with disruption of the outer segments of foveal cones. Functional and anatomical damage was restricted to the fovea. The poppers involved were identified as isopropyl nitrite in 3 cases. Four patients showed anatomical and/or functional improvement over several months after discontinuing popper inhalation. CONCLUSIONS: Repeated inhalation of poppers may be associated with prolonged bilateral vision loss due to the disruption of foveal cone outer segments. Retinal damage may progressively improve following drug discontinuation.


Assuntos
Nitrito de Amila/efeitos adversos , Fóvea Central/efeitos dos fármacos , Drogas Ilícitas , Transtornos Relacionados ao Uso de Substâncias/complicações , Tomografia de Coerência Óptica/métodos , Baixa Visão/induzido quimicamente , Adulto , Seguimentos , Fóvea Central/patologia , Humanos , Masculino , Pessoa de Meia-Idade , Baixa Visão/patologia , Baixa Visão/fisiopatologia , Acuidade Visual/efeitos dos fármacos
3.
J Chromatogr B Analyt Technol Biomed Life Sci ; 878(28): 2905-10, 2010 Oct 15.
Artigo em Inglês | MEDLINE | ID: mdl-20843750

RESUMO

The consumption of psychostimulant amphetamine-like drugs has increased significantly in recent years. Some MDMA metabolites are probably involved in the neurotoxicity and neurodegeneration caused by prolonged use rather than MDMA itself. We recently developed a method to analyze MDMA and its five main metabolites in rat plasma [7]. We have now fully validated this method to the quantification of these drugs in rat urine. We extracted MDMA and its metabolites with Oasis WCX cartridges, separated them on a Nucleodur C18 analytical column and quantified them by ion-trap mass spectrometry. Linearity was excellent: 12.5-1250ng/mL urine for HMA, HMMA, MDA and MDMA, 25-2500ng/mL for HHMA, and 150-7500ng/mL for HHA (r(2)>0.993 for all analytes). The lower limits of quantification were 12.5ng/mL urine for MDMA, MDA, HMA and HMMA, 25ng/mL for HHMA and 150ng/mL for HHA. Reproducibility was good (intra-assay precision=1.7-6.1%; inter-assay precision=0.6-5.7%), as was accuracy (intra-assay deviation=0.1-4.8%; inter-assay deviation=0.7-7.9%). Average recoveries were around 85.0%, except for HHMA (66.2%) and HHA (53.0%) (CV<8.3%). We also checked the stability of stock solutions and the internal standards after freeze-thawing and in the autosampler. Lastly, we measured the MDMA, MDA, HHMA, HHA, HMMA and HMA in urine samples taken over 24h from rats given subcutaneous MDMA.


Assuntos
Cromatografia Líquida de Alta Pressão/métodos , N-Metil-3,4-Metilenodioxianfetamina/urina , Extração em Fase Sólida/métodos , Anfetaminas/química , Anfetaminas/metabolismo , Anfetaminas/urina , Animais , Dopamina/análogos & derivados , Dopamina/química , Dopamina/metabolismo , Dopamina/urina , Estabilidade de Medicamentos , Modelos Lineares , Masculino , Espectrometria de Massas , N-Metil-3,4-Metilenodioxianfetamina/química , N-Metil-3,4-Metilenodioxianfetamina/metabolismo , Ratos , Ratos Sprague-Dawley , Reprodutibilidade dos Testes , Sensibilidade e Especificidade
5.
J Toxicol Clin Toxicol ; 40(1): 77-80, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-11990207

RESUMO

BACKGROUND: Toxicity of 1,4-butanediol, an industrial solvent and a substance of abuse, is still misunderstood and not well documented. To date, only supportive treatments are used in this poisoning. CASE REPORT: The case of a 43-year-old man who ingested 30 mL of a homemade 1,4-butanediol solution and who developed general seizures and coma has been reported here. An intravenous loading dose of fomepizole 10 mg/kg was started on admission and followed by two other doses of 10 mg/kg every 12 hour. He awoke shortly after fomepizole administration. Initial plasma 1,4-butanediol and gamma-hydroxybutyric acid concentrations, measured by gas chromatography-mass spectrometry, were 24 and 222 mg/L, respectively. Subsequent 1,4-butanediol and gamma-hydroxybutyric acid determination suggest that there was some further formate of gamma-hydroxbutyric acid after fomepizole was administered. CONCLUSION: Fomepizole administration appeared safe in this 1,4-butanediol-intoxicated patient. It is unknown whether fomepizole influenced his clinical course, but the rapid awakening observed suggests that it may have been usefuL Further experience is needed, however, to define the efficacy of this antidotal therapy in 1,4-butanediol intoxication.


Assuntos
Antídotos/uso terapêutico , Butileno Glicóis/intoxicação , Pirazóis/uso terapêutico , Solventes/intoxicação , Adulto , Antídotos/administração & dosagem , Antídotos/efeitos adversos , Butileno Glicóis/sangue , Coma/induzido quimicamente , Fomepizol , Humanos , Hidroxibutiratos/análise , Hidroxibutiratos/metabolismo , Infusões Intravenosas , Masculino , Pirazóis/administração & dosagem , Pirazóis/efeitos adversos , Convulsões/induzido quimicamente , Transtornos Relacionados ao Uso de Substâncias/sangue , Transtornos Relacionados ao Uso de Substâncias/metabolismo , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA